Caring Cross, a non-benefit devoted to speeding up the improvement of cutting edge prescriptions and empowering admittance to solutions for all patients, all over the place, and ImmunoAdoptive Cell Therapy (ImmunoACT), a cell and gene therapy...
Cellipont Bioservices, a pharmaceutical company and Adva Biotechnology, an Israel-based private biotechnology organization giving a decentralized, robotized, and productive assembling stage for cutting-edge cell treatments, reported its alliance...
Sobi reported that the European Commission (EC) has sanctioned a sign augmentation for Aspaveli (pegcetacoplan) for treatment of grown-up patients with paroxysmal nocturnal haemoglobinuria (PNH) who have haemolytic anaemia. Aspaveli is as of...
ZygoFix Ltd, a portfolio firm of The Trendlines Group Ltd (Trendlines), has acquired regulatory approval from the US Food and Drug Administration for their zLOCK Lumbar Facet Fixation System. This success was reinforced by strong clinical evidence...
Gossamer Bio, Inc. (Gossamer), a clinical-stage biopharmaceutical organization centered on the progression and commercialization of seralutinib for the treatment of pulmonary hypertension, and Chiesi Farmaceutici S.p.A (Chiesi Gathering)...
Bristol Myers Squibb, a pharmaceutical firm, reported that the European Medicines Agency (EMA) has approved its Sort II variation application for Opdivo (nivolumab) in addition to Yervoy (ipilimumab) for the first-line therapy of grown-up patients...
Naprod Life Sciences (Naprod) announced today the successful renewal of its European Union Goods Manufacturing Practices (EU-GMP) certification for its manufacturing facility in Palghar.
Mediar Therapeutics, Inc., a biotechnology company developing a portfolio of first-in-class therapies to halt fibrosis progression, reported that the first cohort of participants in a phase 1 trial evaluating the safety and tolerability of MTX-463...
The Authentication Solution Providers' Association (ASPA), a proactive advocate in the fight against counterfeiting, spearheads a robust public awareness campaign, particularly within the pharmaceutical industry. Recognising the urgent need to add...
Emcure Pharmaceuticals, one of India’s leading pharmaceutical companies, unveiled its new corporate campaign with the tagline – ‘Cure and Beyond’, featuring cricketer MS Dhoni. In the ever-evolving world of healthcare, Emcure Pharmaceuticals...
, CDSCO.jpg)
